{"id":16056,"date":"2021-11-18T14:04:39","date_gmt":"2021-11-18T14:04:39","guid":{"rendered":"https:\/\/clinlabint.com\/?p=16056"},"modified":"2021-11-18T14:04:39","modified_gmt":"2021-11-18T14:04:39","slug":"thermo-fisher-scientific-unveils-q-digital-pcr-system-for-innovation-in-genetic-analysis","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/thermo-fisher-scientific-unveils-q-digital-pcr-system-for-innovation-in-genetic-analysis\/","title":{"rendered":"Thermo Fisher Scientific unveils Q Digital PCR system for innovation in genetic analysis"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

\r\n\r\n\"\"<\/a>\r\n<\/div><\/p>\n<\/div><\/section>
\n

Thermo Fisher Scientific unveils Q Digital PCR system for innovation in genetic analysis<\/h1>\/ in Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

Thermo Fisher Scientific has introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.<\/strong><\/p>\n

<\/p>\n

dPCR has quickly become the standard for nucleic acid quantification in oncology, cell and gene therapy oncology development and other research applications because its absolute quantification enables higher accuracy and precision. Thermo Fisher recently acquired Combinati and its cutting-edge dPCR technology to rapidly develop and commercialize it alongside an expanding portfolio of assays.<\/p>\n

\u201cThe device overcomes the existing challenges of precision, operation, and turnaround time to provide an industry-best dPCR platform,” explained Amit Chopra, managing director, India, and South Asia, Thermo Fisher Scientific.<\/p>\n

Unlike complex, multi-instrument workflows required for traditional dPCR, the QuantStudio Absolute Q System uses microfluidic array technology and simplified workflows, designed to improve data accuracy and consistency. The device supports the pharmaceutical fraternity in innovating disease management, advancing significantly in generating consistent and accurate data.<\/p>\n

\u201cQuantStudio Absolute Q solution is a fast and simple workflow that offers high-quality data with minimum hands-on time. It integrates all the necessary steps for dPCR \u2013 digitization, thermal cycling, and data acquisition \u2013 into a single instrument. The dPCR is already in use for longitudinal monitoring of cancer-driving mutations in liquid biopsy and precise quantification of gene inserts for cell therapy development,\u201d said Kapil Sood, senior director, Life Sciences Solutions, Thermo Fisher Scientific<\/p>\n<\/div><\/section>
\n

\n